MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%
Sector Heatmap
Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%
BIO — Bio-Rad Laboratories, Inc.Class A
NYSEBio-Rad Laboratories, Inc.Class A
$369.14
+13.57(+3.82%)
- O
- 357.28
- H
- 369.40
- L
- 357.28
- V
- 223.64K
⏱️ End-of-day dataAs of Oct 2, 2026
BIO — Financial Statements
Historical 2-Year Statements| Financial Metric / Line Item | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|
| Fiscal Date | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| Period | quarterly | quarterly | quarterly | quarterly | quarterly | quarterly |
| Year | 2,026.00 | 2,025.00 | 2,025.00 | 2,025.00 | 2,025.00 | 2,024.00 |
| Cash And Cash Equivalents | $50.72M | $52.98M | $39.58M | $36.93M | $52.14M | $48.81M |
| Other Short Term Investments | $105.75M | $101.09M | $102.28M | $100.45M | $113.90M | $117.64M |
| Accounts Receivable | $42.62M | $46.06M | $46.47M | $46.99M | $42.47M | $45.25M |
| Inventory | $77.05M | $74.07M | $78.32M | $79.88M | $79.01M | $76.00M |
| Prepaid Assets | $15.00M | $13.65M | $15.20M | $14.96M | $12.54M | $12.26M |
| Other Current Assets | $30.70M | $27.70M | $23.50M | $19.00M | $36.00M | $30.70M |
| Total Current Assets | $294.21M | $290.62M | $284.20M | $281.11M | $303.66M | $303.03M |
| Properties | $68.94M | $149.26M | $72.05M | $74.01M | $68.17M | $134.37M |
| Goodwill | $132.10M | $133.39M | $154.58M | $156.01M | $112.53M | $111.46M |
| Intangible Assets | $16.68M | $17.43M | $38.84M | $39.69M | $29.61M | $29.36M |
| Investments And Advances | $531.18M | $610.36M | $505.78M | $557.65M | $499.42M | $483.92M |
| Other Non Current Assets | $10.28M | $10.27M | $10.90M | $10.79M | $10.37M | $10.19M |
| Total Non Current Assets | $684.79M | $767.03M | $685.44M | $740.30M | $649.03M | $633.38M |
| Total Assets | $979.00M | $1.06B | $969.64M | $1.02B | $952.69M | $936.41M |
| Accounts Payable | $13.31M | $12.90M | $12.88M | $13.93M | $13.79M | $12.23M |
| Accrued Expenses | $14.84M | $17.23M | $18.28M | $15.78M | $15.74M | $12.42M |
| Short Term Debt | $43.67M | $37.40M | $38.10M | $40.60M | $42.50M | $42.90M |
| Tax Payable | $44.90M | $36.60M | $44.80M | $36.20M | $37.10M | $31.20M |
| Other Current Liabilities | $15.39M | $14.17M | $12.78M | $17.50M | $13.17M | $14.72M |
| Total Current Liabilities | $91.70M | $51.70M | $52.23M | $54.89M | $50.66M | $46.78M |
| Long Term Debt | $94.15M | $134.87M | $135.72M | $136.59M | $132.70M | $133.18M |
| Deferred Liabilities | $88.18M | $105.94M | $87.26M | $96.10M | $84.08M | $81.80M |
| Other Non Current Liabilities | $19.84M | $19.78M | $20.75M | $20.96M | $17.31M | $17.72M |
| Total Non Current Liabilities | $202.17M | $260.59M | $243.73M | $253.65M | $234.09M | $232.70M |
| Total Liabilities | $293.87M | $312.29M | $295.96M | $308.54M | $284.75M | $279.48M |
| Common Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Retained Earnings | $764.92M | $817.63M | $745.63M | $779.82M | $748.04M | $741.64M |
| Other Shareholders Equity | $-23.54M | $-18.91M | $-16.68M | $-15.41M | $-40.98M | $-53.82M |
| Total Shareholders Equity | $685.13M | $745.36M | $673.68M | $712.87M | $667.94M | $656.93M |
| Additional Paid In Capital | $49.05M | $47.60M | $46.19M | $48.46M | $47.57M | $46.32M |
| Treasury Stock | $105.30M | $100.96M | $101.46M | $100.00M | $86.69M | $77.21M |
| Land And Improvements | N/A | $28.90M | N/A | N/A | N/A | $27.80M |
| Accumulated Depreciation | N/A | $-126.10M | N/A | N/A | N/A | $-110.92M |
| Restricted Cash | N/A | N/A | N/A | N/A | N/A | 0.00 |